Literature DB >> 7014985

Immunology of pyelonephritis in the primate model: live versus heat-killed bacteria.

J A Roberts, G J Domingue, L N Martin, J C Kim.   

Abstract

We produced nonobstructive pyelonephritis in the rhesus monkey (Macaca mulatta) by means of a retrograde inoculation of Escherichia coli to the point of pyelotubular backflow. To evaluate the immune response separate from the effects of infection, we introduced heat-killed bacteria in the same fashion. The disease from live bacteria is self-limited and associated with both a local and generalized immune response. The most marked cellular response is in the regional lymph nodes and is more specific to the bacterial antigen than is generalized stimulation of the immune system. Dead bacteria, while eliciting the formation of serum antibody to the O antigen, appear to ablate the cellular response seen with live bacteria. Loss of renal tubules with attended scarring and loss of renal function does occur from live bacteria. This does not appear to be due to the antigen alone (unless a heat labile antigen is responsible), because heat-killed bacteria do not cause renal scarring. Thus, renal damage seems dependent on an active infection and not on the immune response.

Entities:  

Mesh:

Year:  1981        PMID: 7014985     DOI: 10.1038/ki.1981.20

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Vesicoureteral reflux increases the risk of renal scars: a study of unilateral reflux.

Authors:  Joo Hoon Lee; Chang Hee Son; Moo Song Lee; Young Seo Park
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

2.  Attenuation of antibody response to acute pyelonephritis by treatment with antibiotics.

Authors:  D E Neal; M B Kaack; G Baskin; J A Roberts
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis.

Authors:  Alan J Smith; Yue Liu; Haiyan Peng; Rachel Beers; Michael K Racke; Amy E Lovett-Racke
Journal:  J Neuroimmunol       Date:  2011-06-28       Impact factor: 3.478

4.  P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.

Authors:  J A Roberts; M B Kaack; G Baskin; T K Korhonen; S B Svenson; J Winberg
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

5.  [Immunopathology of pyelonephritis].

Authors:  K Rother
Journal:  Klin Wochenschr       Date:  1983-10-17

6.  Biochemical and histologic findings in experimental pyelonephritis due to Ureaplasma urealyticum.

Authors:  W J Pickering; D F Birch; P Kincaid-Smith
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

7.  Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring.

Authors:  P R Meylan; M Markert; J Bille; M P Glauser
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

8.  Cytokine and lymphocyte activation during experimental acute pyelonephritis.

Authors:  J A Roberts; M B Kaack; L N Martin
Journal:  Urol Res       Date:  1995

9.  Maternal immunization with P fimbriae for the prevention of neonatal pyelonephritis.

Authors:  M B Kaack; J A Roberts; G Baskin; G M Patterson
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.